Merck & Co Inc (NYSE:MRK)

81.94
Delayed Data
As of Dec 04
 +0.49 / +0.60%
Today’s Change
65.25
Today|||52-Week Range
92.64
-9.91%
Year-to-Date
Here's Why Biotech Deals Are All the Rage Right Now
8:45am / MotleyFool.com - Paid Partner Content
Encouraging News on COVID-19 Vaccine
Dec 02 / Zacks.com - Paid Partner Content
Is It Too Late to Buy Moderna Stock?
7:25am / MotleyFool.com - Paid Partner Content
ADP Reports 307K New Jobs, Revisions Up
Dec 02 / Zacks.com - Paid Partner Content
New Uses Could Boost Sales of Bristol-Myers and Merck Drugs
Dec 04 / GuruFocus News - Paid Partner Content
Where Will Pfizer Be in 5 Years?
Nov 28 / MotleyFool.com - Paid Partner Content
Should You Sell Your Moderna Stock Now?
Dec 04 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: AZN COVID-19 Vaccine Interim Data, PFE Emergency Use Appeal
Nov 27 / Zacks.com - Paid Partner Content
Merck Just Sold Off Its Moderna Shares for a Huge Gain. Should You?
Dec 03 / MotleyFool.com - Paid Partner Content
Why Moderna Is Less Risky Than You Think
Nov 26 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close81.45
Today’s open81.14
Day’s range81.11 - 81.94
Volume8,255,332
Average volume (3 months)8,143,064
Market cap$202.0B
Data as of 4:19pm ET, 12/04/2020

Growth & Valuation

Earnings growth (last year)+64.36%
Earnings growth (this year)+14.77%
Earnings growth (next 5 years)+8.60%
Revenue growth (last year)+9.75%
P/E ratio18.1
Price/Sales5.04
Price/Book7.83

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+1.37+1.52%
PFEPfizer+0.26+0.65%
ABBVAbbVie+2.53+2.42%
LLYEli Lilly and Co+4.39+3.05%
Data as of 6:25pm ET, 12/04/2020

Financials

Next reporting dateFebruary 4, 2021
EPS forecast (this quarter)$1.38
Annual revenue (last year)$46.6B
Annual profit (last year)$9.8B
Net profit margin21.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Kenilworth, New Jersey

Forecasts